Oncoinvent Investor Relations Material

Oncoinvent is a biotechnology company focused on the research and development of radiopharmaceuticals for the treatment of cancer. The company specializes in designing targeted therapies that deliver radioactive isotopes directly to cancerous tissues, with the goal of enhancing the precision and effectiveness of treatment while minimizing damage to surrounding healthy cells. Oncoinvent’s core technology platform supports the development of injectable products for intraperitoneal and other localized delivery methods. The company serves the healthcare and pharmaceutical sectors through its proprietary research initiatives. The company is headquartered in Oslo, Norway, and its shares are listed on the NOTC.